Latest NICE accreditations
The NICE Accreditation Advisory Committee has today (11 October) accredited the BArrett's Dysplasia and CAncer Taskforce (BAD CAT) for 'An international, multi-disciplinary, evidence-based consensus on the management of Barrett's dysplasia and early adenocarcinoma in the oesophagus'. The committee, which is an independent advisory body has also accredited the guidance production processes of the National Institute for Health and Care Excellence (NICE) Diagnostics Assessment Programme to produce Diagnostic Technologies Guidance.
Professor David Haslam, Chair of the NICE Accreditation Advisory Committee said: "I am pleased to see the excellent standards of these guidance producers recognised through the NICE Accreditation Programme.
"Following their accreditation both can now proudly display the Accreditation Mark - this ‘seal of approval' informs health and social care staff that the guidance has been developed to a quality process, on the appropriate clinical guidelines."
The BArrett's Dysplasia and CAncer (BAD CAT) Taskforce
The BAD CAT consensus group, established in 2009, aims to produce an evidence-based guideline for the best clinical and cost-effective management of high-grade dysplasia and early mucosal cancer in Barrett's oesophagus.
The Accreditation Advisory Committee considered that the processes used by BAD CAT to produce the evidence-based guideline ‘An international, multidisciplinary, evidence-based consensus on the management of Barrett's dysplasia and early adenocarcinoma in the oesophagus (BAD CAT), August 2011' complied with 24 of the 25 criteria for accreditation.
Professor Janusz Jankowski, Queen Mary, University of London and Consultant Gastroenterologist, Leicester said: "There is inconsistency in the management of high grade dysplasia internationally and a real need for guidance in this topic area. We are extremely pleased to receive this NICE accreditation as it will help health care professionals recognise that they are accessing the best available support material and it gives us a real opportunity to have a positive impact on patient health. Oesophageal adenocarcinoma is an aggressive disease and therefore the new evidence contained in this review gives patients a real opportunity to benefit from recent advances in the understanding and management of the premalignant disease."
NICE Diagnostics Assessment Programme
The Diagnostics Assessment Programme was established in 2010. It assesses diagnostic technologies that have the potential to improve health outcomes but whose introduction into mainstream clinical practice may be associated with an increase in cost to the NHS.
The Diagnostics Assessment Programme is appropriate for complex evaluations of diagnostic tests and technologies.
The Diagnostics Assessment Programme manual (revised in December 2011) is used by NICE to produce the Diagnostic Technologies Guidance.
The independent Accreditation Advisory Committee considered that the processes used by the National Institute for Health and Care Excellence Diagnostics Assessment Programme to produce Diagnostic Technologies Guidance complied with all 25 of the criteria for accreditation.
The accredited guidelines from BAD CAT can now be considered alongside NICE guidance as part of the development of NICE quality standards.
NICE quality standards are derived from NICE guidance and other guidance accredited by the NICE Accreditation Programme and are central to supporting the Government's vision for an NHS focused on delivering the best possible outcomes for patients, as detailed in the 2010 NHS White Paper Equity and Excellence - Liberating the NHS.
For more information, please contact Angela Nonis on 0161 2193772 or email@example.com.
1. The final accreditation report s are available at https://www.evidence.nhs.uk/accreditation/accreditation-decisions
2. NICE's Accreditation Programme verifies the most robustly-produced guidance available to health and social care professionals, enabling them to drive quality outcomes that are among the best in the world. It uses rigorous assessment processes based on international standards for guideline development produced by the Appraisal of Guidelines Research & Evaluation collaboration (AGREE).
3. The Accreditation Mark is a registered trademark of the National Institute for Health and Care Excellence. It appears next to titles within search results on the NHS Evidence portal to denote those information sources that have passed the criteria for producing high-quality information.
4. Provided it is relevant to a search, information from accredited sources features on NHS Evidence in the top results, with the Accreditation Mark clearly displayed.
5. An accredited organisation can display the Accreditation Mark publicly as a sign of its high standard achieved in developing information.
6. Accreditation lasts for five years.
The National Institute for Health and Care Excellence (NICE) is the independent organisation responsible for providing national guidance and standards on the promotion of good health and the prevention and treatment of ill health.
NICE produces guidance in three areas of health:
- public health - guidance on the promotion of good health and the prevention of ill health for those working in the NHS, local authorities and the wider public and voluntary sector.
- health technologies - guidance on the use of new and existing medicines, treatments, medical technologies (including devices and diagnostics) and procedures within the NHS.
- clinical practice - guidance on the appropriate treatment and care of people with specific diseases and conditions within the NHS.
NICE produces standards for patient care:
- quality standards - these reflect the very best in high quality patient care, to help healthcare practitioners and commissioners of care deliver excellent services.
- Quality and Outcomes Framework - NICE develops the clinical and health improvement indicators in the QOF, the Department of Health scheme which rewards GPs for how well they care for patients.
NICE provides advice and support on putting NICE guidance and standards into practice through its implementation programme, and it collates and accredits high quality health guidance, research and information to help health professionals deliver the best patient care through NHS Evidence.
This page was last updated: 11 October 2012